Catalyst’s Nancy Myers is looking forward to speaking on a panel at the 4thAgentic AI Innovation Summit on January 12 at 11 am. She will speak alongside Vada A. Perkins, Andrew Robertson, Jimita Parekh, Chris Lee and moderator Brad Pryde. If you are attending, we would love to chat – reach out to us on LinkedIn!
Multistakeholder collaboration, led by Catalyst Healthcare Consulting, to Recommend Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (preprint).
Understanding the patient experience with CAR-T long-term follow-up (LTFU) is essential for building a sustainable model. Catalyst...
Catalyst’s Nancy Myers is looking forward to speaking on a panel at the 4th Agentic AI Innovation Summit on January 12 at 11 am. She will speak alongside Vada A. Perkins, Andrew Robertson, Jimita Parekh, and moderator Brad Pryde. If you are attending, we would love to chat – reach out to us on LinkedIn!
Catalyst CEO, Nancy Myers, had the opportunity to address CBER leadership during OTP’s September 18th public listening meeting titled “Leveraging Knowledge for Facilitating the Development and Review of Cell and Gene Therapies.” Though a PDUFA VII commitment and a required action, meetings like this one provide a critical space for industry and the Agency to share ideas and deliver better outcomes for patients.
.jpg)
Sign up for periodic updates on regulatory policy and events we are attending
